University of Adelaide, Adelaide, SA 5005, Australia.
Obes Surg. 2013 Sep;23(9):1427-30. doi: 10.1007/s11695-013-0890-6.
This paper aims to evaluate, in a clinical context, current creatinine-based formulas commonly used to calculate renal function in morbidly obese patients.
A retrospective analysis was performed of the estimates of renal function of 63 obese or morbidly obese patients undergoing gastric bypass surgery. Each patient's glomerular filtration rate (GFR) was calculated using five methods, both before and after surgery, and these approximations were then compared.
Prior to surgery, the values offered by the five formulas for the renal function of this population ranged widely, by over a factor of 2. After surgery, the three weight-based GFR estimation methods indicated that a significant change in GFR had occurred, but the two non-weight-based formulas showed no significant change in estimated GFR.
At baseline and after significant weight loss, creatinine-based formulas differ twofold in their estimates of renal function of the morbidly obese. An accurate method for calculating these patients' renal function is required to improve patient safety with drug dosing as well as to ensure early detection of renal failure.
本研究旨在评估目前常用于病态肥胖患者肾功能计算的基于肌酐的公式在临床环境中的应用。
对 63 例行胃旁路手术的肥胖或病态肥胖患者的肾功能进行回顾性分析。每位患者的肾小球滤过率(GFR)均使用 5 种方法进行计算,分别在术前和术后进行,并对这些近似值进行比较。
术前,这 5 种公式对该人群肾功能的预测值相差 2 倍以上。术后,3 种基于体重的 GFR 估算方法均表明 GFR 发生了显著变化,但 2 种非体重公式显示估算的 GFR 没有明显变化。
在基线和显著减重后,基于肌酐的公式在病态肥胖患者的肾功能估计方面存在两倍的差异。为了提高药物剂量的患者安全性,并确保早期发现肾衰竭,需要一种准确计算这些患者肾功能的方法。